相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dietary Fermented Soy Extract and Oligo-Lactic Acid Alleviate Chronic Kidney Disease in Mice via Inhibition of Inflammation and Modulation of Gut Microbiota
Li-Xia He et al.
NUTRIENTS (2020)
Targeting claudin-4 enhances CDDP-chemosensitivity in gastric cancer
Yukiko Nishiguchi et al.
Oncotarget (2019)
Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review
Hanna Fjeldheim Dale et al.
NUTRIENTS (2019)
Modulation of Gut Microbiota for Health by Current and Next-Generation Probiotics
Reetta Satokari
NUTRIENTS (2019)
IL-23 in inflammatory bowel diseases and colon cancer
Markus F. Neurath
CYTOKINE & GROWTH FACTOR REVIEWS (2019)
Ovarian Tumor Cell Expression of Claudin-4 Reduces Apoptotic Response to Paclitaxel
Christopher Breed et al.
MOLECULAR CANCER RESEARCH (2019)
Promoter orientation of the immunomodulatory Bacteroides fragilis capsular polysaccharide A (PSA) is off in individuals with inflammatory bowel disease (IBD)
Lucy E. Blandford et al.
GUT MICROBES (2019)
Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response
Laura Martin de la Fuente et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2018)
Detection of B. fragilis group and diversity of bft enterotoxin and antibiotic resistance markers cepA, cfiA and nim among intestinal Bacteroides fragilis strains in patients with inflammatory bowel disease
Marjan Rashidan et al.
ANAEROBE (2018)
Epidemiology of gastrointestinal symptoms in young and middle-aged Swiss adults: prevalences and comorbidities in a longitudinal population cohort over 28 years
Maria Avramidou et al.
BMC GASTROENTEROLOGY (2018)
Claudin-4 Expression Is Associated With Disease-Free Survival in Breast Carcinoma-in-Situ: Mean Follow-up of 8.2 Years
Giuliano M. Duarte et al.
CLINICAL BREAST CANCER (2018)
Comparison of the microbial community structure between inflamed and non-inflamed sites in patients with ulcerative colitis
Atsushi Hirano et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Anti-claudin-4 extracellular domain antibody enhances the antitumoral effects of chemotherapeutic and antibody drugs in colorectal cancer
Rina Fujiwara-Tani et al.
Oncotarget (2018)
A review of vedolizumab and ustekinumab for the treatment of inflammatory bowel diseases
Hang Hock Shim et al.
JGH OPEN (2018)
Epidemiology of inflammatory bowel diseases from west to east
Zsuzsanna Vegh et al.
JOURNAL OF DIGESTIVE DISEASES (2017)
Claudin-4 knockout by TALEN-mediated gene targeting in MDCK cells: Claudin-4 is dispensable for the permeability properties of tight junctions in wild-type MDCK cells
Shinsaku Tokuda et al.
PLOS ONE (2017)
Epidemiology of functional gastrointestinal disorders in children and adolescents: A systematic review
Alexandre Canon Boronat et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
A Population-Based Study on the Epidemiology of Functional Gastrointestinal Disorders in Young Children
Ashish Chogle et al.
JOURNAL OF PEDIATRICS (2016)
Defects in the adherens junction complex (E-cadherin/β-catenin) in inflammatory bowel disease
Shameer Mehta et al.
CELL AND TISSUE RESEARCH (2015)
Intestinal Permeability Regulation by Tight Junction: Implication on Inflammatory Bowel Diseases
Sung Hee Lee
INTESTINAL RESEARCH (2015)
CLAUDINS AND THE MODULATION OF TIGHT JUNCTION PERMEABILITY
Dorothee Guenzel et al.
PHYSIOLOGICAL REVIEWS (2013)
Tacrolimus (FK506) suppresses TNF-α-induced CCL2 (MCP-1) and CXCL10 (IP-10) expression via the inhibition of p38 MAP kinase activation in human colonic myofibroblasts
Tomoki Aomatsu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
'Gut health': a new objective in medicine?
Stephan C. Bischoff
BMC MEDICINE (2011)
Monocyte chemoattractant protein-1 (MCP-1) inhibits the intestinal-like differentiation of monocytes
T. Spoettl et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
分享论文
